Hemophotonics
Innovative medical devices and solutions company.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
€50.0k | Grant | ||
| Total Funding | 000k | ||
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 442 % | (2 %) | 146 % | (35 %) | 13 % | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 43 % | 37 % | 11 % | (29 %) | 46 % | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 34 % | 25 % | 6 % | (25 %) | 32 % | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
HemoPhotonics is a pioneering medical devices company that specializes in developing and commercializing portable, non-invasive, real-time blood flow monitoring devices. Founded in 2013 as a spin-off from the renowned ICFO - The Institute of Photonic Sciences in Barcelona, Spain, the company leverages advanced photonics technology to create innovative solutions for the healthcare sector.
The primary product offered by HemoPhotonics is the Optical Neuro Monitor, which uses a technique called Diffuse Correlation Spectroscopy (DCS). This technology allows for the measurement of hemodynamic parameters—essentially, the dynamics of blood flow within tissues—without the need for invasive procedures like probes, CT scans, or MRIs. This makes it a valuable tool for medical doctors and scientific researchers who require precise and real-time data on blood flow in living tissues.
HemoPhotonics operates in the medical devices market, specifically targeting healthcare professionals and researchers. The company's business model revolves around the sale and customization of its monitoring devices. By tailoring their technology to meet the specific needs of various studies and research projects, HemoPhotonics adds significant value to its offerings. This customization capability not only enhances the utility of their devices but also helps in building long-term relationships with clients.
Revenue is primarily generated through the direct sale of these specialized devices. Additionally, the company may offer support services and customization options, which provide additional streams of income. By focusing on a niche yet critical aspect of medical research and patient care, HemoPhotonics has carved out a unique position in the market.
In summary, HemoPhotonics is a forward-thinking company providing cutting-edge, non-invasive blood flow monitoring solutions that cater to the needs of medical professionals and researchers, thereby contributing to advancements in healthcare and medical science.
Keywords: Medical Devices, Blood Flow Monitoring, Non-Invasive, Real-Time, Photonics, Healthcare, Research, Customization, Diffuse Correlation Spectroscopy, Innovation.